Targeted alpha therapy (r)evolution: emerging nuclides for clinical applications

Keyphrases

• Alpha-emitter 100%
• Major Challenges 50%
• Double-strand Break 50%
• Tumor Targeting Strategy 50%
• Radionuclide Production 50%
• Lead-212 50%
• High Linear Energy Transfer Radiation 50%
• Current Landscape 50%
• Chelate Complexes 50%
• Target Molecules 50%
• Scale-up Production 50%
• Alpha-emitting Radionuclides 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Neoplasm 100%
• Radioisotope 100%
• Chelating Agent 100%
• Clinical Trial 50%
• Astatine 211 50%
• Lead 212 50%
• Actinium 225 50%